Lanreotide

Full Definition

Lanreotide is a synthetic cyclic octapeptide somatostatin analog that binds to somatostatin receptors, particularly subtypes 2 and 5. It is administered as a deep subcutaneous injection every 28 days and is used primarily for the treatment of gastroenteropancreatic neuroendocrine tumors and acromegaly. The medication helps control hormone hypersecretion and can slow tumor growth in certain neuroendocrine malignancies. Common side effects include gastrointestinal symptoms and injection site reactions.

Usage

Usage note: Brand name Somatuline should be capitalized; generic lanreotide is lowercase.

In Context

• "The patient was started on lanreotide 120 mg subcutaneously every 28 days for control of carcinoid symptoms." — Treatment plan
• "Lanreotide therapy resulted in a 50% reduction in 24-hour urinary 5-HIAA levels after three months of treatment." — Follow-up assessment